Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 16,600 shares at $480.92 ($8.0M) on 2026-02-05, disclosed to the SEC on 2026-02-05.
Seasonal sale ($8.0M) by EVP & GENERAL COUNSEL — this insider has traded UTHR in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $480.92 | 477 | $229K | 2.9% |
| 2 | $480.92 | 477 | $229K | 2.9% |
| 3 | $481.93 | 2,363 | $1.1M | 14.2% |
| 4 | $481.93 | 2,363 | $1.1M | 14.2% |
| 5 | $482.57 | 1,103 | $532K | 6.6% |
| 6 | $482.57 | 1,103 |
| $532K |
| 6.6% |
| 7 | $483.92 | 2,748 | $1.3M | 16.6% |
| 8 | $483.92 | 2,748 | $1.3M | 16.6% |
| 9 | $484.92 | 934 | $453K | 5.6% |
| 10 | $484.92 | 934 | $453K | 5.6% |
| 11 | $485.52 | 675 | $328K | 4.1% |
| 12 | $485.52 | 675 | $328K | 4.1% |
| Total | $483.25 avg | 16,600 | $8.0M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |